Definitive experiments would involve murine infection followed by simultaneous sampling of all lymph nodes within BcR transgenic mice to account for migration to non-draining lymph nodes, nasal mucosa and other mucosa-associated lymphoid tissues, as well as skin and liver. The gene discussed is BCR; the disease is infection.